Bacterial Pharyngitis — Symptoms, Self-Diagnosis and Integrative Treatment

Bacterial pharyngitis is an acute inflammation of the pharyngeal mucosa, most commonly associated with group A β-hemolytic streptococcus and less commonly with group C and G streptococci, Fusobacterium necrophorum, Corynebacterium diphtheriae, Neisseria gonorrhoeae, and other bacteria. The disease usually begins suddenly with pronounced pain when swallowing, fever, redness and swelling of the pharynx, enlarged tonsils, the appearance of a whitish-yellow coating, and tenderness of the anterior cervical lymph nodes. Chills, weakness, headache, bad breath, decreased appetite, nausea, and abdominal pain may occur. Cough, runny nose, hoarseness, and conjunctivitis are less characteristic of the classic streptococcal form. The infection is transmitted primarily through droplets of saliva and respiratory secretions, and less commonly through hands, dishes, and shared items. The disease occurs most often in school-age children; in children under three years of age, the typical streptococcal presentation is uncommon, while symptoms may be less pronounced in older adults. In uncomplicated cases, acute manifestations usually persist for several days.

How to Determine Whether You Have Bacterial Pharyngitis

The likelihood of a bacterial cause is increased by sudden onset, a temperature above 38 °C, absence of cough, tender anterior cervical lymph nodes, swollen tonsils with exudate, and the onset of symptoms after contact with an infected person. These signs are used in the Centor and McIsaac scores, but they only allow the probability of infection to be estimated. A white coating alone does not prove a bacterial cause: it also occurs in infectious mononucleosis, candidiasis, and some viral infections. Confirmation may involve a rapid streptococcal antigen test, molecular testing, or culture of a throat swab. In children and adolescents, a negative rapid test in the presence of a characteristic clinical picture should preferably be rechecked by culture or a more sensitive molecular method. An ASO test is not suitable for confirming an ongoing acute process because antibodies appear with a delay. Pronounced runny nose, cough, hoarseness, oral ulcers, or conjunctivitis are more consistent with a viral process; a dense grayish membrane, unilateral bulging of a tonsil, difficulty opening the mouth, an unusual rash, or an association with oral sexual contact requires additional evaluation.

Red Flags

Emergency medical care is required if there is difficulty breathing or noisy breathing, increasing neck swelling, inability to swallow water or saliva, pronounced drooling, or a sensation that the throat is closing. Severe unilateral pain, a muffled or nasal-sounding voice, displacement of the uvula, inability to open the mouth widely, and swelling around a tonsil may indicate a peritonsillar abscess and require urgent evaluation by an ENT specialist. A dense gray-white membrane that bleeds when removal is attempted, especially when accompanied by neck swelling and systemic intoxication, requires immediate exclusion of diphtheria. High fever with chills, confusion, a drop in blood pressure, or rapidly spreading swelling may indicate a septic complication. Recurrent deterioration after a brief improvement, unilateral neck swelling, chest pain, and shortness of breath in an adolescent or young adult require exclusion of Lemierre syndrome. Urgent evaluation is also necessary in cases of dehydration, a marked decrease in urine output, seizures, a hemorrhagic rash, or pronounced neck stiffness. Children, pregnant women, older adults, and patients with immunodeficiency require earlier medical assessment even when symptoms are moderate.

Initial Self-Care Methods for Bacterial Pharyngitis

Until medical evaluation, physical activity should be reduced, adequate sleep should be ensured, and smoking, alcohol, spicy seasonings, acidic beverages, excessively hot food, and irritating aerosols should be avoided. Indoor air should preferably be maintained at a temperature of 19–22 °C and a relative humidity of 40–60%, with the room aired regularly. Soft warm foods are preferable: puréed soups, porridge, eggs, stewed vegetables, and fermented dairy products if well tolerated. Warm water, unsweetened compote, or weak tea can be consumed in small portions of 150–250 ml every one to two hours. In cases of heart or kidney failure, edema, or disorders of water and electrolyte balance, fluid volume should be determined individually.

For gargling, 240 ml of warm water is mixed with half a teaspoon of salt and 0.5 g of a 10% dry extract of Kaempferia parviflora. The solution is mixed until the extract is evenly dispersed, the throat is gargled for 20–30 seconds several times during each procedure, and the solution should not be swallowed. Gargling helps reduce secretions and coating, while Kaempferia provides additional local antibacterial and anti-inflammatory effects. This method is suitable only for children and adults who are able to gargle safely. If burning, swelling, or increased pain develops, use should be discontinued.

Concentrated salt, vinegar, citric acid, alcohol, kerosene, hydrogen peroxide, aggressive iodine solutions, and undiluted essential oils should not be used. The coating should not be removed with a cotton swab or metal objects, the neck should not be intensely heated in the presence of pronounced swelling, leftover antibiotics from previous treatment should not be started, and a prescribed antibiotic course should not be discontinued after the first improvement. Until the diagnosis is clarified, it is advisable to use separate dishes, wash hands more frequently, and avoid close contact. Temperature, breathing, ability to drink, urine output, the appearance of a rash, and asymmetry of the throat should be monitored. If the condition worsens or there is no noticeable improvement within 48–72 hours, repeat medical evaluation is required.

Stages and Possible Progression of Bacterial Pharyngitis

Formal division into stages is not required for ordinary streptococcal pharyngitis. Infection is usually followed by an incubation period lasting several days, after which sore throat, fever, and inflammation of the regional lymph nodes develop rapidly. Most uncomplicated episodes gradually resolve, but an unrecognized infection can spread to adjacent tissues. Peritonsillar and retropharyngeal abscess, cervical lymphadenitis, otitis, sinusitis, scarlet fever, bacteremia, and Lemierre syndrome may occur. Delayed immune complications of streptococcal infection include acute rheumatic fever and post-streptococcal glomerulonephritis. Recurrence may be promoted by ongoing contact with a source of infection, incomplete therapy, pathogen resistance, chronic carriage, immunodeficiency, and an unrecognized abscess. Persistent sore throat requires investigation for another cause, because an ordinary acute process should not indefinitely progress into a “chronic infection” without an additional diagnosis.

Integrative Treatment Methods for Bacterial Pharyngitis

An integrative regimen is selected with consideration of the identified or suspected pathogen, the severity of coating and swelling, temperature, the condition of the cervical lymph nodes, the presence of cough, hoarseness, an allergic component, and concomitant diseases. In laboratory-confirmed streptococcal infection, herbal therapy may be used together with a prescribed antibiotic, but it should not be used on one’s own to replace etiotropic treatment when there is a high risk of systemic and purulent complications.

The systemic anti-infective component may be based on 10% extracts of Andrographis paniculata, Forsythia suspensa, Lonicera japonica, Houttuynia cordata, Scutellaria baicalensis, Coptis chinensis, Acanthus ebracteatus, and Illicium verum.

Andrographis, Forsythia, Lonicera, and Houttuynia form the main antibacterial and anti-inflammatory direction; Scutellaria supports regulation of the inflammatory response; Coptis may be considered in a persistent or purulent process; Acanthus and Illicium provide additional antiseptic, secretolytic, and reparative effects. Simultaneous inclusion of all extracts is not mandatory: the composition of the regimen is determined by clinical objectives, contraindications, tolerability, and drug interactions.

Propolis 3800 may be used as an additional systemic antimicrobial and immunomodulatory component. It is excluded in patients with allergies to propolis, honey, or other bee products, as well as in a severe allergic phenotype of bronchial asthma. Urticaria, mucosal edema, bronchospasm, and anaphylactic reactions may occur.

For direct contact with the mucosa, saline gargling with a 10% extract of Kaempferia galanga and the ABP-153 oil infusion are used. The basic version of ABP-153 without DMSO is intended primarily for superficial and cavity processes and may be applied to accessible inflamed areas of the posterior pharyngeal wall and palatal arches using a soaked swab.

Topical formulations are best used between meals and before bedtime to maintain contact with the mucosa. If pronounced burning, increased swelling or cough, or difficulty breathing occurs, use should be discontinued. ABP-153D is not required for superficial pharyngitis because deep transmembrane delivery is not the primary therapeutic objective.

In cases of high fever, chills, and general intoxication, Antipyretic Compound is used. If pain, swelling, and inflammation predominate without pronounced hyperthermia, priority is given to the anti-inflammatory Five Root Compound.

Continuous simultaneous use of both compounds is usually unnecessary. Five Root Compound does not produce the direct ulcerogenic effect typical of NSAIDs and does not suppress platelet function through cyclooxygenase blockade; however, individual hypersensitivity and interactions with other systemic anti-inflammatory agents must be taken into account. Use of the antipyretic formula should not mask persistent high fever when an abscess or another deep infection is developing.

When cervical lymph nodes are enlarged and tender, a lymphatic support block is used: Murdannia loriformis for immune and lymphatic regulation, Houttuynia cordata for control of inflammation and exudation, Ruscus aculeatus to support microcirculation and lymphatic drainage, and Squalene 1000 for membrane and antioxidant support. Pronounced unilateral enlargement of a lymph node, softening, redness of the overlying skin, or rapid enlargement of the lesion requires medical evaluation rather than lymphotropic support alone.

For dryness, burning, and painful swallowing, Althaea officinalis is used to create a protective mucilaginous layer. It should be separated in time from antibiotics and other oral medications because its coating polysaccharides may slow their absorption.

Pulmonaria officinalis is more appropriate when pharyngitis is accompanied by a dry or minimally productive cough, respiratory tract irritation, and difficulty clearing secretions. In cases of cough, hoarseness, and mucosal irritation, the “Cough and Hoarseness” Bolus is used and allowed to dissolve slowly in the mouth.

Because it contains licorice, the bolus requires caution in arterial hypertension, edema, heart failure, and hypokalemia. Combination with loop and thiazide diuretics, cardiac glycosides, and systemic glucocorticosteroids may increase potassium loss, blood pressure elevation, and the risk of cardiac arrhythmias.

Vernonia cinerea is used in pharyngitis accompanied by fever, cough, and inflammation of the lower respiratory tract, particularly in patients who smoke. Smoker’s Boluses are intended primarily for chronic irritation of the respiratory tract by tobacco smoke and should not automatically be combined with Vernonia and the “Cough and Hoarseness” Bolus because the formulas contain overlapping components.

Allergy Mixture Capsules are included only in a mixed infectious-allergic process, pronounced allergic edema, hypersecretion, or allergic cough. The formula already contains Andrographis paniculata and Murdannia loriformis, so the additional use of separate extracts of Andrographis paniculata and Murdannia loriformis creates duplication and requires reassessment of the regimen.

Boswellia serrata, Nigella sativa, and Curcuma longa are additional anti-inflammatory components for pronounced, prolonged, or recurrent inflammation. Simultaneous inclusion of all three is usually excessive.

Turmeric and Nigella require caution when anticoagulants and antiplatelet agents are used because of the potential increase in bleeding. Turmeric is contraindicated in biliary obstruction and requires separate assessment in cholelithiasis and acute pancreatitis. Nigella may additionally lower blood pressure and blood glucose levels, which should be taken into account during antihypertensive and glucose-lowering therapy.

Ganoderma lucidum is used primarily for recurrent disease, secondary immunodeficiency, and during the recovery period after infection. It does not replace an antibiotic in confirmed streptococcal pharyngitis and is not used as a means of urgently reducing pharyngeal swelling.

Mentha piperita may reduce pain and the subjective sensation of heat, but on a dry, inflamed mucosa it may intensify burning and irritation and is therefore considered a reserve component. Cinnamomum cassia has antimicrobial activity, but it is not applied directly to inflamed mucosa and is used only as an additional systemic component. Aegle marmelos is more appropriate in chronic pharyngitis or when infection is accompanied by diarrhea, dyspepsia, and other gastrointestinal manifestations.

For concomitant tension-type headache or cervical-occipital muscle tension, the Aromatic Cooling Oil Sukaya oil infusion is used. It is applied only to intact skin of the temples, occipital region, and neck. The product is not used on the oropharyngeal mucosa, inside the mouth, on erosions or cracks, and is not intended to treat the bacterial infection itself.

What You Need to Know About Standard Protocols of Modern Medicine

An antibiotic for bacterial pharyngitis should preferably be prescribed after laboratory confirmation of streptococcal infection or in a special clinical situation in which the physician considers waiting for the result to be dangerous. When signs of a viral illness are present, antibiotics do not shorten the duration of the infection, but they disrupt the microbiota, cause adverse reactions, and create selective pressure that promotes the development of resistant bacteria.

The usual first-line drugs for confirmed streptococcal pharyngitis are phenoxymethylpenicillin or amoxicillin; when oral administration is not possible, benzathine benzylpenicillin may be used. Penicillins are contraindicated in patients who have previously experienced anaphylaxis, angioedema, bronchospasm, or another immediate reaction to β-lactam antibiotics. They may cause nausea, abdominal pain, diarrhea, antibiotic-associated colitis, oral and genital candidiasis, urticaria, and drug-related rash.

Critically dangerous complications of penicillins include anaphylactic shock, airway edema, severe bullous skin reactions, hemolytic anemia, thrombocytopenia, neutropenia, interstitial nephritis, seizures caused by drug accumulation in renal failure, drug-induced hepatitis, and cholestasis. Amoxicillin particularly often causes a widespread rash in infectious mononucleosis, so it should not be prescribed solely on the basis of the appearance of tonsillar coating without excluding Epstein–Barr virus infection. Penicillins may reduce the elimination of methotrexate, leading to severe hematological and hepatic toxicity, alter the anticoagulant effect of warfarin, and interact with probenecid and other uricosuric agents.

Benzathine benzylpenicillin is administered exclusively intramuscularly. Accidental intravenous or intra-arterial administration may result in severe vascular injury, limb ischemia, tissue necrosis, neurological disorders, cardiorespiratory collapse, and death. Anaphylaxis, pronounced local pain, infiltration, nerve injury, and rare severe embolic complications may occur after injection. The drug must not be administered unless there is readiness to provide emergency care in the event of an allergic reaction.

First-generation cephalosporins, including cephalexin and cefadroxil, are used in certain forms of penicillin allergy, but they should not be started without a physician after previous anaphylaxis or another severe immediate reaction to β-lactams. Nausea, diarrhea, candidiasis, rash, urticaria, and contact allergic manifestations may occur. More serious complications include anaphylaxis, severe antibiotic-associated colitis, interstitial nephritis, neutropenia, thrombocytopenia, hemolytic anemia, drug-induced liver injury, and seizures due to drug accumulation in patients with renal failure.

In cases of immediate allergy to β-lactams, azithromycin, clarithromycin, or clindamycin may be considered; however, streptococcal resistance to these drugs varies considerably. Unjustified or repeated use of macrolides promotes selection of resistant strains and may make subsequent treatment ineffective.

Azithromycin may cause nausea, diarrhea, abdominal pain, headache, candidiasis, elevated liver enzymes, cholestatic hepatitis, and, rarely, liver failure. It prolongs the QT interval and may provoke torsades de pointes ventricular tachycardia, syncope, and sudden cardiac death. Its use is particularly dangerous in patients with pre-existing QT prolongation, bradycardia, heart failure, hypokalemia, hypomagnesemia, and when combined with antiarrhythmics, antipsychotics, certain antidepressants, and other drugs that affect cardiac rhythm.

Clarithromycin has an even greater potential for drug interactions through CYP3A4. It may increase concentrations of certain statins, leading to rhabdomyolysis and acute renal failure, enhance the effects of warfarin and oral anticoagulants, and increase concentrations of colchicine, benzodiazepines, carbamazepine, digoxin, calcium channel blockers, and immunosuppressants. Severe liver injury, hypoglycemia, hearing impairment, QT prolongation, ventricular arrhythmias, and a pronounced drop in blood pressure may occur with unsafe combinations.

Clindamycin is particularly dangerous because of the risk of Clostridioides difficile infection and pseudomembranous colitis. This complication may develop during treatment or weeks after treatment has ended and may present with profuse diarrhea, abdominal pain, fever, dehydration, toxic megacolon, intestinal perforation, sepsis, and death. Nausea, esophagitis, candidiasis, drug-induced hepatitis, neutropenia, thrombocytopenia, anaphylaxis, and severe skin reactions may also occur. If severe or persistent diarrhea develops, medications that suppress intestinal motility should not be taken without medical supervision.

Tetracyclines and co-trimoxazole are not considered reliable agents for eradication of Streptococcus pyogenes from the pharynx. Prescribing them instead of an active drug may temporarily reduce some symptoms but may fail to eliminate the pathogen or prevent complications. Co-trimoxazole may additionally cause severe skin reactions, agranulocytosis, thrombocytopenia, hyperkalemia, kidney injury, drug-induced hepatitis, and dangerous interactions with warfarin, methotrexate, ACE inhibitors, angiotensin receptor blockers, and spironolactone.

If diphtheria, gonococcal pharyngitis, Lemierre syndrome, or a peritonsillar or retropharyngeal abscess is suspected, standard treatment of streptococcal pharyngitis is insufficient. Special investigations, isolation measures, different antibacterial regimens, airway assessment, and, if an abscess has formed, surgical drainage are required. Attempts to suppress symptoms at home may lead to airway obstruction, sepsis, internal jugular vein thrombosis, mediastinitis, and other life-threatening complications.

To reduce pain and fever, paracetamol or ibuprofen may be used with consideration of contraindications. When the total dose is exceeded, several combination medications are used simultaneously, or in the presence of fasting, severe liver disease, or alcohol abuse, paracetamol may cause massive hepatic necrosis, acute liver failure, encephalopathy, impaired coagulation, coma, and death. The danger is that symptoms may be mild during the first hours of severe poisoning.

Ibuprofen and other NSAIDs may cause erosions, ulcers, and massive gastrointestinal bleeding without pronounced preceding symptoms. They reduce renal blood flow and may provoke fluid retention, edema, increased blood pressure, acute renal failure, and decompensation of heart failure. Bronchospasm, severe allergic reactions, liver injury, and an increased risk of thrombotic cardiovascular complications may occur. Ibuprofen is contraindicated in active gastrointestinal ulceration or bleeding, severe renal and heart failure, NSAID-induced bronchospasm, and late pregnancy. Combining it with anticoagulants, antiplatelet drugs, systemic glucocorticosteroids, and certain antidepressants significantly increases the risk of bleeding.

Aspirin should not be given to children or adolescents during an acute infection because of the risk of Reye syndrome, a severe disorder involving the liver and brain that may cause vomiting, impaired consciousness, seizures, cerebral edema, coma, and possible death.

Systemic glucocorticosteroids are not a routine treatment for bacterial pharyngitis. They may rapidly reduce pain and swelling while simultaneously suppressing the immune response and masking progression of a deep infection or abscess formation. Even short-term use may cause hyperglycemia, increased blood pressure, insomnia, psychiatric disturbances, dyspepsia, and increased susceptibility to infection. Repeated courses increase the risk of ulcerative and hemorrhagic gastrointestinal injury, osteoporosis, adrenal suppression, cataracts, glaucoma, and metabolic disturbances.

A reliable percentage of complete recovery and absence of recurrence within two years has not been established for bacterial pharyngitis as a heterogeneous group of diseases. The clinical outcome depends on the pathogen, its susceptibility, the accuracy of diagnosis, the timeliness of treatment, adherence to the prescribed regimen, and the presence of deep purulent complications.

Simultaneous use of antibiotics, NSAIDs, paracetamol, antihistamines, and systemic glucocorticosteroids may create a cumulative burden on the liver, kidneys, gastrointestinal tract, cardiovascular, nervous, immune, and hematopoietic systems, mask abscess development, provoke severe colitis, bleeding, arrhythmia, drug-induced hepatitis, and the development of resistant microflora. Alternative integrative approaches based on individually selected herbal formulas make it possible to target inflammation, pain, swelling, and the condition of the mucosa and generally do not produce the same degree of aggressive systemic damaging effects associated with prolonged or unjustified combined use of chemically synthesized medications.

Why Dosages and Duration of Treatment Are Not Specified in the Article

The same disease may occur at different stages in different people, vary in severity, develop complications, and coexist with other diseases. To select the dosage and duration of treatment, a specialist needs to assess the current phase of the disease, its duration, severity of symptoms, the presence of chronic or recurrent disease, associated conditions, previous illnesses, age, body weight, the condition of the liver, kidneys, cardiovascular, nervous, endocrine, and other systems, as well as medications already being taken and possible interactions. A universal dosage for all patients may be insufficient and ineffective or excessive and dangerous. Therefore, the article describes possible directions of therapy but does not replace an individualized clinical and pharmacological assessment. If necessary, you can ask a short question in the comments to this article, while in more complex cases you can schedule a consultation with a clinical pharmacologist specializing in integrative medicine via this link.